Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of 14.37% and Operating profit at -7.02% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.52%
0%
-17.52%
6 Months
-9.99%
0%
-9.99%
1 Year
-28.7%
0%
-28.7%
2 Years
-3.07%
0%
-3.07%
3 Years
-57.72%
0%
-57.72%
4 Years
-57.78%
0%
-57.78%
5 Years
-59.59%
0%
-59.59%
Novolog (Pharm UP 1966) Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.37%
EBIT Growth (5y)
-7.02%
EBIT to Interest (avg)
5.13
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
4.47
Tax Ratio
30.00%
Dividend Payout Ratio
63.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.94%
ROE (avg)
7.14%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.73
EV to EBIT
10.83
EV to EBITDA
3.78
EV to Capital Employed
2.50
EV to Sales
0.22
PEG Ratio
0.14
Dividend Yield
307.73%
ROCE (Latest)
23.04%
ROE (Latest)
5.43%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
506.90
689.90
-26.53%
Operating Profit (PBDIT) excl Other Income
17.70
37.40
-52.67%
Interest
3.90
3.30
18.18%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.20
2.70
-55.56%
Operating Profit Margin (Excl OI)
6.50%
20.60%
-1.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -26.53% vs 48.14% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -55.56% vs -77.31% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,021.60
1,643.50
23.01%
Operating Profit (PBDIT) excl Other Income
138.00
114.80
20.21%
Interest
12.60
12.90
-2.33%
Exceptional Items
-10.50
-51.20
79.49%
Consolidate Net Profit
41.00
-39.40
204.06%
Operating Profit Margin (Excl OI)
34.60%
30.70%
0.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 23.01% vs 8.99% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 204.06% vs -176.65% in Dec 2023






